T1	Age 2 13	42-year-old
T2	Sex 14 19	woman
T3	Sign_symptom 50 54	lump
E1	Sign_symptom:T3 
T4	Biological_structure 37 49	right breast
R1	MODIFY Arg1:T4 Arg2:E1	
T5	Sign_symptom 67 71	pain
E2	Sign_symptom:T5 
T6	Biological_structure 56 66	lower back
R2	MODIFY Arg1:T6 Arg2:E2	
T7	Sign_symptom 73 87	loss of height
E3	Sign_symptom:T7 
T8	Sign_symptom 96 104	kyphosis
E4	Sign_symptom:T8 
T9	Sign_symptom 109 121	hepatomegaly
E5	Sign_symptom:T9 
T10	Diagnostic_procedure 128 136	biopsies
E6	Diagnostic_procedure:T10 
T11	Biological_structure 146 157	breast lump
R3	MODIFY Arg1:T11 Arg2:E6	
T12	Disease_disorder 165 181	ductal carcinoma
E7	Disease_disorder:T12 
T13	Diagnostic_procedure 275 281	biopsy
E8	Diagnostic_procedure:T13 
T14	Biological_structure 290 321	ipsilateral axillary lymph node
R4	MODIFY Arg1:T14 Arg2:E8	
T15	Disease_disorder 349 370	ductal adenocarcinoma
E9	Disease_disorder:T15 
T16	Detailed_description 338 348	metastatic
R5	MODIFY Arg1:T16 Arg2:E9	
T17	Diagnostic_procedure 399 418	Computed tomography
E10	Diagnostic_procedure:T17 
T18	Disease_disorder 444 462	metastatic disease
E11	Disease_disorder:T18 
T19	Biological_structure 466 471	bones
R6	MODIFY Arg1:T19 Arg2:E11	
T20	Biological_structure 473 479	pleura
T21	Biological_structure 484 489	liver
R7	MODIFY Arg1:T20 Arg2:E11	
R8	MODIFY Arg1:T21 Arg2:E11	
T22	Detailed_description 433 443	widespread
R9	MODIFY Arg1:T22 Arg2:E11	
T23	Medication 581 592	trastuzumab
E12	Medication:T23 
T24	Medication 597 622	taxane-based chemotherapy
E13	Medication:T24 
T25	Sign_symptom 651 659	response
E14	Sign_symptom:T25 
T26	Detailed_description 643 650	partial
T27	Detailed_description 631 642	significant
R10	MODIFY Arg1:T26 Arg2:E14	
R11	MODIFY Arg1:T27 Arg2:E14	
T28	Medication 699 711	chemotherapy
E15	Medication:T28 
T29	Detailed_description 689 698	induction
R12	MODIFY Arg1:T29 Arg2:E15	
T30	Medication 735 744	tamoxifen
E16	Medication:T30 
T31	Medication 749 760	trastuzumab
E17	Medication:T31 
T32	Duration 768 777	19 months
E18	Duration:T32 
T33	Sign_symptom 811 819	seizures
E19	Sign_symptom:T33 
T34	Diagnostic_procedure 829 848	computed tomography
E20	Diagnostic_procedure:T34 
T35	Biological_structure 824 828	head
R13	MODIFY Arg1:T35 Arg2:E20	
T36	Sign_symptom 866 876	metastasis
E21	Sign_symptom:T36 
T37	Biological_structure 884 901	left frontal lobe
R14	MODIFY Arg1:T37 Arg2:E21	
T38	Therapeutic_procedure 935 943	resected
E22	Therapeutic_procedure:T38 
T39	Medication 965 974	tamoxifen
E23	Medication:T39 
T40	Medication 979 990	trastuzumab
E24	Medication:T40 
T41	Diagnostic_procedure 1023 1037	plasma samples
E25	Diagnostic_procedure:T41 
T42	Date 1069 1086	Four months after
E26	Date:T42 
T43	Sign_symptom 1120 1127	lesions
E27	Sign_symptom:T43 
T44	Biological_structure 1114 1119	liver
T45	Detailed_description 1104 1113	enlarging
R15	MODIFY Arg1:T44 Arg2:E27	
R16	MODIFY Arg1:T45 Arg2:E27	
T46	Sign_symptom 1138 1156	metastatic deposit
E28	Sign_symptom:T46 
T47	Biological_structure 1164 1174	left ovary
R17	MODIFY Arg1:T47 Arg2:E28	
T48	Medication 1241 1250	lapatinib
E29	Medication:T48 
T49	Medication 1255 1267	capecitabine
E30	Medication:T49 
T50	Sign_symptom 1282 1296	stable disease
E31	Sign_symptom:T50 
T51	Duration 1301 1310	12 months
E32	Duration:T51 
T52	Sign_symptom 1334 1355	General deterioration
E33	Sign_symptom:T52 
T53	Sign_symptom 1376 1395	disease progression
E34	Sign_symptom:T53 
T54	Biological_structure 1403 1408	chest
R18	MODIFY Arg1:T54 Arg2:E34	
T55	Disease_disorder 1443 1460	pleural effusions
E35	Disease_disorder:T55 
T56	Detailed_description 1433 1442	bilateral
R19	MODIFY Arg1:T56 Arg2:E35	
T57	Sign_symptom 1424 1431	nodules
E36	Sign_symptom:T57 
T58	Biological_structure 1414 1423	pulmonary
R20	MODIFY Arg1:T58 Arg2:E36	
T59	Sign_symptom 1486 1490	mass
E37	Sign_symptom:T59 
T60	Biological_structure 1465 1485	posterior chest wall
R21	MODIFY Arg1:T60 Arg2:E37	
T61	Outcome 1611 1615	died
E38	Outcome:T61 
T62	Therapeutic_procedure 1573 1582	Treatment
E39	Therapeutic_procedure:T62 
A1	POLARITY E39 NEG
T63	Date 1617 1631	4 months later
E40	Date:T63 
T64	Clinical_event 20 29	presented
E41	Clinical_event:T64 
*	OVERLAP E41 E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11
R22	BEFORE Arg1:E11 Arg2:E12	
*	OVERLAP E12 E13 E14 E15
R23	BEFORE Arg1:E15 Arg2:E16	
*	OVERLAP E16 E17 E18
R24	BEFORE Arg1:E18 Arg2:E19	
*	OVERLAP E19 E20 E21 E22
R25	BEFORE Arg1:E22 Arg2:E23	
*	OVERLAP E23 E24 E25
R26	BEFORE Arg1:E25 Arg2:E26	
*	OVERLAP E26 E27 E28
R27	BEFORE Arg1:E28 Arg2:E29	
*	OVERLAP E29 E30
R28	BEFORE Arg1:E30 Arg2:E31	
*	OVERLAP E31 E32
R29	BEFORE Arg1:E32 Arg2:E33	
*	OVERLAP E33 E34 E36 E35 E37 E42
T65	Diagnostic_procedure 1513 1566	Eastern Cooperative Oncology Group performance status
E42	Diagnostic_procedure:T65 
T66	Lab_value 1567 1570	2â€“3
R30	MODIFY Arg1:T66 Arg2:E42	
R31	BEFORE Arg1:E42 Arg2:E39	
R32	BEFORE Arg1:E39 Arg2:E38	
*	OVERLAP E38 E40
T67	Duration 2034 2047	last 500 days
E43	Duration:T67 
T68	Clinical_event 2060 2069	follow-up
E44	Clinical_event:T68 
R33	MODIFY Arg1:E43 Arg2:E44	
T69	Sign_symptom 1633 1639	Tumour
E45	Sign_symptom:T69 
T70	Clinical_event 1665 1674	diagnosis
E46	Clinical_event:T70 
T71	Biological_structure 1692 1698	breast
T72	Biological_structure 1718 1737	axillary lymph node
R34	MODIFY Arg1:T71 Arg2:E45	
R35	MODIFY Arg1:T72 Arg2:E45	
T73	Date 1746 1761	after 19 months
E47	Date:T73 
T74	Disease_disorder 1777 1787	metastasis
E48	Disease_disorder:T74 
T75	Biological_structure 1771 1776	brain
R36	MODIFY Arg1:T75 Arg2:E48	
T76	Diagnostic_procedure 1808 1815	autopsy
E49	Diagnostic_procedure:T76 
T77	Date 1816 1829	after 3 years
E50	Date:T77 
T78	Therapeutic_procedure 1833 1842	treatment
E51	Therapeutic_procedure:T78 
T79	Diagnostic_procedure 1996 2002	plasma
E52	Diagnostic_procedure:T79 
T80	Detailed_description 1989 1995	Serial
R37	MODIFY Arg1:T80 Arg2:E52	
R38	AFTER Arg1:E40 Arg2:E45	
*	OVERLAP E45 E46
R39	BEFORE Arg1:E46 Arg2:E47	
*	OVERLAP E47 E48
R40	BEFORE Arg1:E48 Arg2:E49	
*	OVERLAP E49 E50
R41	AFTER Arg1:E50 Arg2:E51	
R42	AFTER Arg1:E51 Arg2:E52	
*	OVERLAP E52 E44
